Cargando…
Current clinical landscape of oncolytic viruses as novel cancer immunotherapeutic and recent preclinical advancements
Oncolytic viruses (OVs) have been gaining attention in the pharmaceutical industry as a novel immunotherapeutic and therapeutic adjuvant due to their ability to induce and boost antitumor immunity through multiple mechanisms. First, intrinsic mechanisms of OVs that enable exploitation of the host im...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458317/ https://www.ncbi.nlm.nih.gov/pubmed/36091031 http://dx.doi.org/10.3389/fimmu.2022.953410 |